Editorial: Current Status of Two Adjuvanted Malaria Vaccines and the World Health Organization (WHO) Strategy to Eradicate Malaria by 2030. [PDF]
Parums DV.
europepmc +1 more source
The Importance of Exercising Caution When Comparing Results from Malaria Vaccines Administered on the EPI Schedule and on a Seasonal Schedule. [PDF]
Birkett A, Miller RS, Soisson LA.
europepmc +1 more source
mRNA delivery of circumsporozoite protein epitope-based malaria vaccines induces protection in a mouse model. [PDF]
Wu NR +26 more
europepmc +1 more source
Insights from modelling malaria vaccines for policy decisions: the focus on RTS,S. [PDF]
Galactionova K, Smith TA, Penny MA.
europepmc +1 more source
Recent perspectives in clinical development of malaria vaccines. [PDF]
Feehan J, Plebanski M, Apostolopoulos V.
europepmc +1 more source
Circumsporozoite Surface Protein-based malaria vaccines: a review. [PDF]
Almeida MEM +3 more
europepmc +1 more source
Rethinking malaria vaccines: perspectives on currently approved malaria vaccines in India's path to elimination. [PDF]
Ranjha R +5 more
europepmc +1 more source
B cell clonal expansion and mutation in the immunoglobulin heavy chain variable domain in response to Pfs230 and Pfs25 malaria vaccines. [PDF]
Coelho CH +3 more
europepmc +1 more source
Development of a sporozoite malaria vaccine [PDF]
Nussenzweig, Victor +1 more
openaire +4 more sources
Editorial: The First Monoclonal Antibody Vaccine to Prevent Malaria Heralds a New Era of Malaria Vaccines to the Plasmodium falciparum Circumsporozoite Protein (PfCSP). [PDF]
Parums DV.
europepmc +1 more source

